The progesterone antagonist mifepristone/RU486 blocks the negative effect on life span caused by mating in female Drosophila. 2015

Gary N Landis, and Matthew P Salomon, and Daniel Keroles, and Nicholas Brookes, and Troy Sekimura, and John Tower
Molecular and Computational Biology Program, Department of Biological Sciences, University of Southern California, Los Angeles, CA 90089-2910, USA.

Mating causes decreased life span in female Drosophila. Here we report that mifepristone blocked this effect, yielding life span increases up to +68%. Drug was fed to females after mating, in the absence of males, demonstrating function in females. Mifepristone did not increase life span of virgin females or males. Mifepristone reduced progeny production but did not reduce food intake. High-throughput RNA sequencing was used to identify genes up-regulated or down-regulated upon mating, and where the change was reduced by mifepristone. Five candidate positive regulators of life span were identified, including dosage compensation regulator Unr and three X-linked genes: multi sex combs (PcG gene), Dopamine 2-like receptor and CG14215. The 37 candidate negative genes included neuropeptide CNMamide and several involved in protein mobilization and immune response. The results inform the interpretation of experiments involving mifepristone, and implicate steroid hormone signaling in regulating the trade-off between reproduction and life span.

UI MeSH Term Description Entries
D008136 Longevity The normal length of time of an organism's life. Length of Life,Life Span,Lifespan,Life Spans,Lifespans
D008297 Male Males
D010641 Phenotype The outward appearance of the individual. It is the product of interactions between genes, and between the GENOTYPE and the environment. Phenotypes
D011374 Progesterone The major progestational steroid that is secreted primarily by the CORPUS LUTEUM and the PLACENTA. Progesterone acts on the UTERUS, the MAMMARY GLANDS and the BRAIN. It is required in EMBRYO IMPLANTATION; PREGNANCY maintenance, and the development of mammary tissue for MILK production. Progesterone, converted from PREGNENOLONE, also serves as an intermediate in the biosynthesis of GONADAL STEROID HORMONES and adrenal CORTICOSTEROIDS. Pregnenedione,Progesterone, (13 alpha,17 alpha)-(+-)-Isomer,Progesterone, (17 alpha)-Isomer,Progesterone, (9 beta,10 alpha)-Isomer
D012098 Reproduction The total process by which organisms produce offspring. (Stedman, 25th ed) Human Reproductive Index,Human Reproductive Indexes,Reproductive Period,Human Reproductive Indices,Index, Human Reproductive,Indexes, Human Reproductive,Indices, Human Reproductive,Period, Reproductive,Periods, Reproductive,Reproductive Index, Human,Reproductive Indices, Human,Reproductive Periods
D004268 DNA-Binding Proteins Proteins which bind to DNA. The family includes proteins which bind to both double- and single-stranded DNA and also includes specific DNA binding proteins in serum which can be used as markers for malignant diseases. DNA Helix Destabilizing Proteins,DNA-Binding Protein,Single-Stranded DNA Binding Proteins,DNA Binding Protein,DNA Single-Stranded Binding Protein,SS DNA BP,Single-Stranded DNA-Binding Protein,Binding Protein, DNA,DNA Binding Proteins,DNA Single Stranded Binding Protein,DNA-Binding Protein, Single-Stranded,Protein, DNA-Binding,Single Stranded DNA Binding Protein,Single Stranded DNA Binding Proteins
D004331 Drosophila melanogaster A species of fruit fly frequently used in genetics because of the large size of its chromosomes. D. melanogaster,Drosophila melanogasters,melanogaster, Drosophila
D005260 Female Females
D005838 Genotype The genetic constitution of the individual, comprising the ALLELES present at each GENETIC LOCUS. Genogroup,Genogroups,Genotypes
D006727 Hormone Antagonists Chemical substances which inhibit the function of the endocrine glands, the biosynthesis of their secreted hormones, or the action of hormones upon their specific sites. Antagonists, Hormone

Related Publications

Gary N Landis, and Matthew P Salomon, and Daniel Keroles, and Nicholas Brookes, and Troy Sekimura, and John Tower
January 2021, The journals of gerontology. Series A, Biological sciences and medical sciences,
Gary N Landis, and Matthew P Salomon, and Daniel Keroles, and Nicholas Brookes, and Troy Sekimura, and John Tower
October 1991, Human reproduction (Oxford, England),
Gary N Landis, and Matthew P Salomon, and Daniel Keroles, and Nicholas Brookes, and Troy Sekimura, and John Tower
January 2022, Frontiers in aging,
Gary N Landis, and Matthew P Salomon, and Daniel Keroles, and Nicholas Brookes, and Troy Sekimura, and John Tower
June 2007, Experimental gerontology,
Gary N Landis, and Matthew P Salomon, and Daniel Keroles, and Nicholas Brookes, and Troy Sekimura, and John Tower
June 2017, Biogerontology,
Gary N Landis, and Matthew P Salomon, and Daniel Keroles, and Nicholas Brookes, and Troy Sekimura, and John Tower
July 1988, Human reproduction (Oxford, England),
Gary N Landis, and Matthew P Salomon, and Daniel Keroles, and Nicholas Brookes, and Troy Sekimura, and John Tower
January 2021, Frontiers in genetics,
Gary N Landis, and Matthew P Salomon, and Daniel Keroles, and Nicholas Brookes, and Troy Sekimura, and John Tower
June 2008, Antimicrobial agents and chemotherapy,
Gary N Landis, and Matthew P Salomon, and Daniel Keroles, and Nicholas Brookes, and Troy Sekimura, and John Tower
November 1992, Prostaglandins,
Gary N Landis, and Matthew P Salomon, and Daniel Keroles, and Nicholas Brookes, and Troy Sekimura, and John Tower
March 1990, The Journal of endocrinology,
Copied contents to your clipboard!